350 Epizód

  1. Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing

    Közzétéve: 2019. 06. 27.

  2. Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life

    Közzétéve: 2019. 06. 20.

  3. Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world

    Közzétéve: 2019. 06. 13.

  4. Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party

    Közzétéve: 2019. 06. 06.

  5. Episode 65: A special episode from the halls of the ASCO meeting

    Közzétéve: 2019. 06. 04.

  6. Episode 64: Feuding professors, failing businesses, and journalism 101

    Közzétéve: 2019. 05. 30.

  7. Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer

    Közzétéve: 2019. 05. 23.

  8. Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials

    Közzétéve: 2019. 05. 16.

  9. Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

    Közzétéve: 2019. 05. 09.

  10. Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

    Közzétéve: 2019. 05. 02.

  11. Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

    Közzétéve: 2019. 04. 25.

  12. Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print

    Közzétéve: 2019. 04. 18.

  13. Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

    Közzétéve: 2019. 04. 11.

  14. Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound

    Közzétéve: 2019. 04. 04.

  15. Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

    Közzétéve: 2019. 03. 28.

  16. Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores

    Közzétéve: 2019. 03. 21.

  17. Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

    Közzétéve: 2019. 03. 14.

  18. Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation

    Közzétéve: 2019. 03. 07.

  19. Episode 51: CEOs at the Senate, merger mania, and sleuthing startups

    Közzétéve: 2019. 02. 28.

  20. Episode 50: A big scoop on opioid marketing

    Közzétéve: 2019. 02. 22.

15 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site